Tiny Float Breakout Idea (Nasdaq: ZVSA) Is Developing First-In-Class Drugs For Unmet Medical Needs

For Friday's opening bell, consider getting ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA) on your radar.

StockWireNews Tiny Float Breakout Idea (Nasdaq: ZVSA) Is Developing First-In-Class Drugs For Unmet Medical Needs January 9th Greetings Readers, For Friday's opening bell, consider getting ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA) on your radar. Here's the main reason why... ZVSA is a low float profile. With roughly 1.02Mn shares, its minuscule float could create an environment of extreme volatility in moments. And if the right potential catalyst comes along, it could act as the spark for volatility to run rampant. ZyVersa Therapeutics, Inc. (ZVSA) is a clinical stage specialty biopharmaceutical company leveraging advanced proprietary technologies to develop first-in-class drugs for patients with inflammatory or kidney diseases with high unmet medical needs. They are well positioned in the rapidly emerging inflammasome space with a highly differentiated monoclonal antibody, Inflammasome ASC Inhibitor IC 100, and in kidney disease with phase 2 Cholesterol Efflux MediatorTM VAR 200. The lead indication for IC 100 is obesity with metabolic complications, and for VAR 200, focal segmental glomerulosclerosis (FSGS). Each therapeutic area offers a "pipeline within a product," with potential for numerous indications. The total accessible market is over $100Bn. Find key sources here: ZVSA Presentation. ----- Coverage is officially initiated on ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA). When updates are available, I'll have them out quickly. Talk soon. Sincerely, Kai Parker StockWireNews (Always Remember The St-ock Prices Could Be Significantly Lower Now From The Dates I Provided.)

StockWireNews (stockwirenews . com) is owned by SWN Media LLC, a limited liability company. Data is provided from third-party sources and StockWireNews ("SWN") is not responsible for its accuracy. Make sure to always do your own research and due diligence on any day and swing profile I bring to your attention. We do not provide personalized fin-ancial advice, are not finan-cial advisors, and our opinions are not suitable for all in-vest-ors. SWN Media LLC has not been compensated for the January 9th and 10th, 2025's profile on (ZVSA:US). Neither SWN Media LLC or its member own shares of (ZVSA:US). Please see important disclosure information here: www.stockwirenews.net/disclosure Unsubscribe Stock Wire News 160 West Camino Real Unit 886 Boca Raton, Florida 33432 United States